Team will identify which ASFV proteins induce protective immune responses, the optimal vaccine dose and a way to differentiate infected from vaccinated pigs.
In line with the Company’s Fix, Fund, Propel approach, Jill Bieker Stefanelli, Ph.D. joins Board, adding precision medicine and product development depth in support of stated strategy to advance innovative technology to market. Separately, Alexander L. Cappello steps down.DUBLIN, Ohio (BUSINESS WIRE) Navidea Bioph.
In line with the Company’s Fix, Fund, Propel approach, Jill Bieker Stefanelli, Ph.D. joins Board, adding precision medicine and product development depth in support of stated strategy to. | June 1, 2023